Cancer Treatment: An Interdisciplinary Approach

1. Auflage 2023
ISBN: 978-3-031-43982-7
Verlag: Springer Nature Switzerland

Buch, Englisch, Band 2, 426 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 822 g

Reihe: Interdisciplinary Cancer Research

Cancer treatment is a challenging issue, while the treatment modalities have extended from traditional surgery, chemotherapy, and radiation therapy to new therapeutic approaches, including targeted therapy, immunotherapy, stem cell transplantation, and hormone therapy. Therefore, an interdisciplinary approach is needed to find a better therapeutic protocols in order to increase the prognosis and quality of life of patients with cancer.

The second volume of the “Interdisciplinary Cancer Research” series, entitled “Cancer Treatment: An Interdisciplinary Approach” publishes comprehensive volumes on different cancer treatment modalities and presents the most updated and peer-reviewed articles on cancer therapy. This interdisciplinary series is of special value to researchers and practitioners working on cell biology, immunology, hematology, biochemistry, genetics, oncology and related fields. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value for researchers and clinicians who wish to extend their knowledge on cancer treatment.

Zielgruppe

Research

Autoren/Hrsg.

Rezaei, Nima

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung

Inhaltsverzeichnis

Cancer: A Complex Problem Requiring Interdisciplinary Research.- Tumor Immunology and Immunotherapy.- New Approaches Targeting Immuno-oncology and Tumor Microenvironment.- Tumor Infiltrating Lymphocytes as Markers of the Antitumor Therapy Efficacy: Myth or Reality?.- Recent Innovative Approaches to Intensify the Efficacy and Safety of CAR-T Cell Therapy in Cancers.- An Updated Focus on Immune Checkpoint Inhibitors and Tubulointerstitial Nephritis.- Cancer Stem Cell as a Target for Immunotherapeutic Approach.- Immunological Properties of Manipulated Hematopoietic Stem Cell Grafts.- Recent Development of Quinoline Derivatives as Anticancer Agents: 2015-2022.- Antitumor Immunotherapy: Effect of COVID-19 in Cancer Patients.- The Use of Immunotherapy in Cancer Patients with Autoimmune Diseases.- The Effects of Low-dose Non-ionizing and Ionizing Radiation on Wound Healing and Cancer.- How Is Cancer Under the Sea? Hyperbaric Oxygen Therapy in Cancer.- Interventional Oncology Techniques: APrimer for Non-Users.- Future Perspectives of Phytochemicals in Cancer Therapy.- Integrated Palliative Cancer Care: From an Interdisciplinary Perspective.- Correction to: Cancer: A Complex Problem Requiring Interdisciplinary Research.

Über Autor(innen)

Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital.  Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research and Technologies, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the Founder of Universal Scientific Education and Research Network (USERN). Prof. Rezaei has already been the Director of more than 100 research projects and has designed and participated in several international collaborative projects. Prof. Rezaei is the editor, editorial assistant, or editorial board member of more than 40 international journals. He has edited more than 50 international books, has presented more than 500 lectures/posters in congresses/meetings, and has published more than 1,200 scientific papers in the international journals.